Cantargia AB

OSTO:CANTA (Sweden)  
kr 1.80 (-1.7%) Nov 29
At Loss
P/B:
6.75
Market Cap:
kr 330.08M ($ 30.28M)
Enterprise V:
kr 270.27M ($ 24.79M)
Volume:
569.22K
Avg Vol (2M):
355.47K
Trade In:
Volume:
569.22K
At Loss
Avg Vol (2M):
355.47K

Business Description

Description
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.62
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.4
9-Day RSI 21.83
14-Day RSI 23.76
6-1 Month Momentum % -27.82
12-1 Month Momentum % -16.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.41
Quick Ratio 2.41
Cash Ratio 2

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.1

Financials (Next Earnings Date:2025-02-21)

OSTO:CANTA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cantargia AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -1.07
Beta 2.11
Volatility % 82.2
14-Day RSI 23.76
14-Day ATR (kr) 0.118982
20-Day SMA (kr) 2.0396
12-1 Month Momentum % -16.65
52-Week Range (kr) 1.782 - 5.2
Shares Outstanding (Mil) 183.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cantargia AB Filings

Filing Date Document Date Form
No Filing Data

Cantargia AB Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Cantargia AB Frequently Asked Questions

What is Cantargia AB(OSTO:CANTA)'s stock price today?
The current price of OSTO:CANTA is kr1.80. The 52 week high of OSTO:CANTA is kr5.20 and 52 week low is kr1.78.
When is next earnings date of Cantargia AB(OSTO:CANTA)?
The next earnings date of Cantargia AB(OSTO:CANTA) is 2025-02-21.
Does Cantargia AB(OSTO:CANTA) pay dividends? If so, how much?
Cantargia AB(OSTO:CANTA) does not pay dividend.

Press Release

Subject Date
No Press Release